1. Home
  2. STK vs CMPS Comparison

STK vs CMPS Comparison

Compare STK & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbia Seligman Premium Technology Growth Fund Inc

STK

Columbia Seligman Premium Technology Growth Fund Inc

HOLD

Current Price

$38.06

Market Cap

694.8M

Sector

Finance

ML Signal

HOLD

Logo COMPASS Pathways Plc American Depository Shares

CMPS

COMPASS Pathways Plc American Depository Shares

HOLD

Current Price

$5.61

Market Cap

778.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STK
CMPS
Founded
N/A
2020
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
694.8M
778.7M
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
STK
CMPS
Price
$38.06
$5.61
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$26.57
AVG Volume (30 Days)
40.2K
2.4M
Earning Date
01-01-0001
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.05
$2.25
52 Week High
$41.46
$8.90

Technical Indicators

Market Signals
Indicator
STK
CMPS
Relative Strength Index (RSI) 42.98 39.28
Support Level $38.21 $4.78
Resistance Level $40.72 $7.02
Average True Range (ATR) 1.11 0.41
MACD -0.08 -0.11
Stochastic Oscillator 15.08 28.44

Price Performance

Historical Comparison
STK
CMPS

About STK Columbia Seligman Premium Technology Growth Fund Inc

Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Share on Social Networks: